DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME7TXV2

Real-time Bid/Ask 12:29:22 12/06/2024 BST
209.41 EUR / 210.81 EUR -0.61% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+3.51%
1 month+1.75%
Date Price Change
11/06/24 211.4 -0.44%
10/06/24 212.3 +0.06%
07/06/24 212.2 +1.19%
06/06/24 209.7 +0.82%
05/06/24 208 -0.67%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 05:58 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXV
ISINDE000ME7TXV2
Date issued 29/01/2024
Cap 250 $
Last trading day 20/12/2024
Maturity 20/12/2024 (192 Days)
Parity 1 : 1
Emission price 206.6
Emission volume N/A
Payment day 31/12/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 3.461 %
Sideways yield 3.950 %
Sideways yield pa 7.549 %
Outperformance point 259 $
Break even 226.01 €
Highest since issue 212.4
Lowest since issue 200.8
Spread 1.48
Spread %0.70%
Distance Cap -15.06 $
Distance Cap %-6.41%
Max. earning 22.3
Max. earning % 10.61 %

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
234.9 USD
Average target price
278.7 USD
Spread / Average Target
+18.62%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW